Sign In

Communications of the ACM

ACM TechNews

Preparing for a Future Pandemic with AI

View as: Print Mobile App Share:
A closeup look at the coronavirus.

Researchers at Pacific Northwest National Laboratory are applying graph neural networks, detailed molecular modeling, and artificial intelligence powered by causal reasoning to study fundamental questions about treatments for COVID-19.

Credit: Stephanie King/Pacific Northwest National Laboratory

Artificial intelligence (AI)-driven investigations into COVID treatments by scientists at the U.S. Department of Energy's Pacific Northwest National Laboratory (PNNL) are yielding insights for application to future pandemic responses.

PNNL's Jeremy Zucker and colleagues used a counterfactual AI framework to simulate biochemical data collected from hypothetical patients with severe COVID-19 infections; each fictitious patient had different viral loads, received a different dose of a drug, and either recovered or died.

The analysis delivered more precise information about the drug's potential benefit to individuals, compared with algorithms that just predicted average patient post-treatment outcomes.

Researchers at PNNL and the University of Washington also combined high-throughput biochemical measurements and AI-based screening to extract one molecule with promising antiviral activity against SARS-CoV-2 out of 13,000.

From Pacific Northwest National Laboratory
View Full Article


Abstracts Copyright © 2021 SmithBucklin, Washington, DC, USA


No entries found

Sign In for Full Access
» Forgot Password? » Create an ACM Web Account